IP Library Granted Patent US 11,771,908
Granted Patent B2
US 11,771,908 · App. 16/911,221 · Granted Oct 3, 2023

Systems and methods for treatment of dry eye

Inventors: Douglas Michael Ackermann (San Francisco, CA); Daniel Palanker (Palo Alto, CA); James Donald Loudin (Houston, TX); Garrett Cale Smith (San Francisco, CA); Victor Wayne McCray (San Jose, CA); Brandon McNary Felkins (Half Moon Bay, CA)
Assignee: The Board of Trustees of the Leland Stanford Junior University
A61N1/37205A61N1/3606A61N1/36046A61N1/36142A61N1/3756A61N1/3787A61N1/36057A61N1/37211
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,771,908
App. No.
16/911,221
Granted
Oct 3, 2023
Kind
B2
Abstract

A stimulation system stimulates anatomical targets in a patient for treatment of dry eye. The system may include a controller and a microstimulator. The controller may be implemented externally to or internally within the microstimulator. The components of the controller and microstimulator may be implemented in a single unit or in separate devices. When implemented separately, the controller and microstimulator may communicate wirelessly or via a wired connection. The microstimulator may generate pulses from a controller signal and apply the signal via one or more electrodes to an anatomical target. The microstimulator may not have any intelligence or logic to shape or modify a signal. The microstimulator may be a passive device configured to generate a pulse based on a signal received from the controller. The microstimulator may shape or modify a signal. Waveforms having different frequency, amplitude and period characteristics may stimulate different anatomical targets in a patient.

Claims (40)

1. A method for treating dry eye in a patient, by stimulating comprising:

implanting a microstimulator adjacent to one or more nerves that innervate a lacrimal gland of the patient;

positioning a controller in proximity to the microstimulator when the patient is wearing a pair of eyeglasses with the controller embedded therein;

transferring a waveform generated by the controller to the microstimulator;

applying by the microstimulator a stimulation to the lacrimal gland from the waveform generated by the controller embedded in the pair of eyeglasses; and

recharging the controller embedded in the pair of eyeglasses worn by the patient after the applying stimulation step.

2. The method of claim 1 , wherein the microstimulator is adjacent the lacrimal gland fully implanted within an orbit of a patient's eye.

3. The method of claim 1 , wherein the microstimulator is adjacent and directly contacting the lacrimal gland.

4. The method of claim 1 , wherein the microstimulator is adjacent to and at least partially penetrating into the lacrimal gland.

5. The method of claim 1 , wherein the microstimulator is adjacent to and fully implanted into or completely within the lacrimal gland.

6. The method of claim 1 , wherein adjacent to the lacrimal gland is about, within or partially in the lacrimal gland.

7. The method of claim 1 , wherein the microstimulator is fully implanted within the orbit of the eye.

8. The method of claim 1 , wherein the stimulation selectively stimulates the one or more nerves that innervate the lacrimal gland.

9. The method of claim 8 , wherein the stimulation selectively stimulates the one or more nerves that innervate the lacrimal gland without moving the eye in the vertical or horizontal direction.

10. The method of claim 8 , wherein the stimulation selectively stimulates the one or more nerves that innervate the lacrimal gland without stimulating the ocular muscles.

11. The method of claim 8 , wherein the stimulation selectively stimulates the one or more nerves that innervate the lacrimal gland without stimulating the superior rectus, lateral rectus, levator palpebrae superioris, retina or corresponding motor nerves.

12. The method of claim 8 , wherein the autonomic efferent fibers are selectively stimulated over the sensory afferent fibers.

13. The method of claim 8 , wherein the autonomic efferent fibers are selectively stimulated over the A-delta pain fibers.

14. The method of claim 8 , wherein the autonomic efferent fibers are selectively stimulated over the C pain fibers.

15. The method of claim 1 , wherein after the implanting step the microstimulator is implanted into the fossa for the lacrimal gland.

16. The method of claim 1 , wherein after the implantation step the microstimulator conforms to the fossa for the lacrimal gland after implantation.

17. The method of claim 1 , wherein the stimulation comprises a current having a pulse amplitude between about 500 μA to about 25 mA.

18. The method of claim 1 , wherein the stimulation comprises a pulse amplitude, a pulse width, and a pulse frequency, and one or more of the pulse amplitude, pulse width, or pulse frequency is varied over the treatment period.

19. The method of claim 1 , further comprising coupling the controller to a wrist watch worn by the patient.

20. A method for treating dry eye in a patient, by stimulating comprising:

implanting a microstimulator adjacent to one or more nerves that innervate a lacrimal gland of the patient, wherein the microstimulator is adjacent to and fully implanted into or completely within the lacrimal gland;

positioning a controller in proximity to the microstimulator when the patient is wearing a pair of eyeglasses with the controller embedded therein;

transferring a waveform generated by the controller to the microstimulator; and

applying by the microstimulator a stimulation to the lacrimal gland from the waveform generated by the controller embedded in the pair of eyeglasses.

21. A method for treating dry eye in a patient, by stimulating comprising:

implanting a microstimulator adjacent to one or more nerves that innervate a lacrimal gland of the patient, wherein the microstimulator is fully implanted within the orbit of the eye;

positioning a controller in proximity to the microstimulator when the patient is wearing a pair of eyeglasses with the controller embedded therein;

transferring a waveform generated by the controller to the microstimulator; and

applying by the microstimulator a stimulation to the lacrimal gland from the waveform generated by the controller embedded in the pair of eyeglasses.

22. A method for treating dry eye in a patient, by stimulating comprising:

implanting a microstimulator adjacent to one or more nerves that innervate a lacrimal gland of the patient;

positioning a controller in proximity to the microstimulator when the patient is wearing a pair of eyeglasses with the controller embedded therein;

coupling the controller to a wrist watch;

transferring a waveform generated by the controller to the microstimulator; and

applying by the microstimulator a stimulation to the lacrimal gland from the waveform generated by the controller embedded in the pair of eyeglasses.

Continuity (10)
Continuation 16195719 · Nov 19, 2018
Continuation 15828950 · Dec 1, 2017
Continuation 14816846 · Aug 3, 2015
Continuation 14561107 · Dec 4, 2014
Continuation 13298042 · Nov 16, 2011
Provisional Application 61433652 · Jan 18, 2011
Provisional Application 61433649 · Jan 18, 2011
Provisional Application 61433645 · Jan 18, 2011
Provisional Application 61414293 · Nov 16, 2010
Related Publication 20210008379A1 · Jan 14, 2021